Sponsored by: GE Healthcare

Molecular Imaging: Page 40

Nuclear medicine staff face redeployment and PPE problems
By AuntMinnieEurope.com staff writers
The British Nuclear Medicine Society has found that nuclear medicine workload in the country fell by 65% during the COVID-19 pandemic, as nearly half of staff were redeployed, and 8% of survey respondents had little or no access to the required personal protective equipment (PPE), the U.K. Society of Radiographers has reported.
June 28, 2020
2019 11 06 21 06 2992 Nuclear Medicine Gamma Camera 400
ITM signs supply deals with Point Biopharma
By AuntMinnieEurope.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München has signed supply agreements with radiopharmaceutical Point Biopharma for ITM's EndolucinBeta radiopharmaceutical precursor.
June 23, 2020
2016 08 24 09 43 13 537 Hands Shaking V3 400
Support builds for Ireland's preclinical imaging center
By AuntMinnieEurope.com staff writers
The Science Foundation Ireland (SFI) Research Infrastructure Programme has pledged 3.4 million euros in funding for the new National Preclinical Imaging Center.
June 17, 2020
2016 12 20 12 32 59 732 Irish Flag 400
PET helps guide therapy for Hodgkin's lymphoma
By AuntMinnieEurope.com staff writers
FDG-PET can help determine which younger patients with newly diagnosed early-stage unfavorable Hodgkin's lymphoma don't need treatment with radiation therapy, German researchers have reported at the virtual European Hematology Association (EHA) congress, held between 11 and 21 June.
June 14, 2020
2018 03 19 15 16 7892 2018 03 19 Ukraine Thumbjpg
Italian team unveils novel data on PET/CT of breast cancer
By Kate Madden Yee
Researchers from Milan have found that FDG-PET/CT can identify breast cancer metastases predicted by elevated tumor marker values in asymptomatic patients who have undergone locoregional therapy. They published their results on 9 June in Oncology.
June 11, 2020
2020 06 11 19 45 6304 Pet Scan 400
NanoMab joins U.K. radionuclide therapy project
By AuntMinnieEurope.com staff writers
Biopharmaceutical firm NanoMab has signed on as an industrial partner in the U.K. Engineering and Physical Research Council Programme for Next-Generation Imaging and Therapy with Radionuclides.
June 9, 2020
2020 06 10 16 56 3372 Radiotherapy2 400
IAEA expands SAFRON to support radionuclide therapy
By AuntMinnieEurope.com staff writers
The International Atomic Energy Association (IAEA) has expanded its Safety in Radiation Oncology (SAFRON) radiotherapy patient safety tool to support radionuclide therapy.
June 8, 2020
2020 06 09 20 17 5049 Iaea 400
Curium files for approvals of germanium-68 tracer
By AuntMinnieEurope.com staff writers
Nuclear medicine firm Curium has filed regulatory applications in the U.S. and Europe for germanium-68, a radiopharmaceutical used in PET imaging.
June 8, 2020
2018 12 11 00 02 7009 Atom Nuclear Lab 400
WMIS switches annual meeting to virtual conference
By AuntMinnieEurope.com staff writers
The World Molecular Imaging Society (WMIS) said that its World Molecular Imaging Congress (WMIC) scheduled for 7-10 October will now be a fully virtual event in order to protect the health and well-being of attendees, staff, and the public.
June 3, 2020
2020 06 04 18 55 5906 Conference Business 400
How can FDG-PET/CT be best used for breast cancer?
By Kate Madden Yee
FDG-PET/CT can be an effective tool when it comes to breast cancer staging and treatment evaluation, but it still shouldn't be used for diagnosis, a Spanish expert told attendees at a webinar held on 28 May by the European Society for Hybrid, Molecular, and Translational Imaging (ESHIMT).
May 31, 2020
2020 06 04 16 17 7893 2020 06 04 Slide57 B
ITM changes name of isotope subsidiary
By AuntMinnieEurope.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München has changed the name of its isotope technologies subsidiary from ITG Isotope Technologies Garching to ITM Medical Isotopes.
May 27, 2020
2018 12 11 00 02 7009 Atom Nuclear Lab 400
Retinal imaging goes high resolution
By Belle Dumé
Age-related macular degeneration affects 26% of Europeans over 60, but its early signs are hard to detect. Swiss researchers have developed a technique that makes it possible to observe the retinal cells involved in the disease in vivo.
May 24, 2020
2020 05 22 18 51 4514 2020 05 22 Transscleral Optical Phase Imaging 20200522182457
Previous Page
Page 40 of 121
Next Page